Personal information

No personal information available

Activities

Collapse all

Works (30)

The effect of oral iron with or without multiple micronutrients on hemoglobin concentration and hemoglobin response among nonpregnant Cambodian women of reproductive age: a 2 x 2 factorial, double-blind, randomized controlled supplementation trial.

2017-05 | Journal article
DOI: 10.3945/ajcn.116.140996
PMID: 28490515
Contributors: Karakochuk CD; Barker MK; Whitfield KC; Barr SI; Vercauteren SM; Devlin AM; Hutcheon JA; Houghton LA; Prak S; Hou K et al.
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

Business Planning for a Campus-Wide Biobank.

2017-02 | Journal article
DOI: 10.1089/bio.2016.0077
PMID: 28151006
Contributors: Tarling TE; Lasser F; Carter C; Matzke LA; Dhugga G; Arora N; Dee S; LeBlanc J; Babinsky S; O'Donoghue S et al.
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

How Biobanks Are Assessing and Measuring Their Financial Sustainability.

2017-02 | Journal article
DOI: 10.1089/bio.2016.0086
PMID: 27869475
Contributors: Brown T; Kelly DD; Vercauteren SM; Wilson WH; Werner A
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

Comparison of four immunoassays to measure serum ferritin concentrations and iron deficiency prevalence among non-pregnant Cambodian women and Congolese children.

2017-01 | Journal article
DOI: 10.1515/cclm-2016-0421
PMID: 27337742
Contributors: Karakochuk CD; Whitfield KC; Rappaport AI; Barr SI; Vercauteren SM; McLean J; Hou K; Talukder A; Houghton LA; Bailey KB et al.
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

von Willebrand disease type 2B.

2017-01 | Journal article
DOI: 10.1182/blood-2016-09-729434
PMID: 28126959
Contributors: McGinnis E; Vercauteren SM
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

von Willebrand disease type 2B.

2016-12 | Journal article
DOI: 10.1182/blood-2016-08-729459
PMID: 27932330
Contributors: McGinnis E; Vercauteren SM
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

The significance of peripheral blood minimal residual disease to predict early disease response in patients with B-cell acute lymphoblastic leukemia.

2016-10 | Journal article
DOI: 10.1111/ijlh.12535
PMID: 27339737
Contributors: Setiadi A; Owen D; Tsang A; Milner R; Vercauteren S
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

Opinions of Adolescents and Parents About Pediatric Biobanking.

2016-04 | Journal article
DOI: 10.1016/j.jadohealth.2015.12.015
PMID: 27013273
Contributors: Kong CC; Tarling TE; Strahlendorf C; Dittrick M; Vercauteren SM
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

The Homozygous Hemoglobin EE Genotype and Chronic Inflammation Are Associated with High Serum Ferritin and Soluble Transferrin Receptor Concentrations among Women in Rural Cambodia.

2015-12 | Journal article
DOI: 10.3945/jn.115.218636
PMID: 26491125
Contributors: Karakochuk CD; Whitfield KC; Rappaport AI; Barr SI; Vercauteren SM; McLean J; Prak S; Hou K; Talukder A; Devenish R et al.
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

Elevated levels of iron in groundwater in Prey Veng province in Cambodia: a possible factor contributing to high iron stores in women.

2015-06 | Journal article
DOI: 10.2166/wh.2014.297
PMID: 26042988
Contributors: Karakochuk CD; Murphy HM; Whitfield KC; Barr SI; Vercauteren SM; Talukder A; Porter K; Kroeun H; Eath M; McLean J et al.
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

Evaluation of two methods to measure hemoglobin concentration among women with genetic hemoglobin disorders in Cambodia: a method-comparison study.

2015-02 | Journal article
DOI: 10.1016/j.cca.2014.12.021
PMID: 25542983
Contributors: Karakochuk CD; Janmohamed A; Whitfield KC; Barr SI; Vercauteren SM; Kroeun H; Talukder A; McLean J; Green TJ
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

Genetic hemoglobin disorders rather than iron deficiency are a major predictor of hemoglobin concentration in women of reproductive age in rural prey Veng, Cambodia.

2015-01 | Journal article
DOI: 10.3945/jn.114.198945
PMID: 25527668
Contributors: Karakochuk CD; Whitfield KC; Barr SI; Lamers Y; Devlin AM; Vercauteren SM; Kroeun H; Talukder A; McLean J; Green TJ
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

Funding sources for Canadian biorepositories: the role of user fees and strategies to help fill the gap.

2014-10 | Journal article
DOI: 10.1089/bio.2014.0052
PMID: 25314324
Contributors: Barnes RO; Schacter B; Kodeeswaran S; CTRNet Management Committee; Watson PH
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

Nodular sclerosis Hodgkin lymphoma with classic Reed-Sternberg cells.

2014-08 | Journal article
DOI: 10.1182/blood-2014-04-571745
PMID: 25259393
PMC: PMC4133504
Contributors: Li SJ; Vercauteren SM
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

Policy recommendations for addressing privacy challenges associated with cell-based research and interventions.

2014-02 | Journal article
DOI: 10.1186/1472-6939-15-7
PMID: 24485220
PMC: PMC3914710
Contributors: Ogbogu U; Burningham S; Ollenberger A; Calder K; Du L; El Emam K; Hyde-Lay R; Isasi R; Joly Y; Kerr I et al.
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

Permission to contact (PTC)--a strategy to enhance patient engagement in translational research.

2013-08 | Journal article
DOI: 10.1089/bio.2013.0023
PMID: 24845592
Contributors: Cheah S; O'Donoghue S; Daudt H; Dee S; LeBlanc J; Braun L; Barnes R; Vercauteren S; Boone RH; Watson PH
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

Auer rods in mature granulocytes of a patient with mixed lineage leukemia.

2012-05 | Journal article
DOI: 10.1182/blood-2011-08-369835
PMID: 22724140
Contributors: Dmitrienko S; Vercauteren S
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

T cells of patients with myelodysplastic syndrome are frequently derived from the malignant clone.

2012-02 | Journal article
DOI: 10.1111/j.1365-2141.2011.08872.x
PMID: 25289412
PMC: PMC4191868
Contributors: Vercauteren SM; Starczynowski DT; Sung S; McNeil K; Salski C; Jensen CL; Bruyere H; Lam WL; Karsan A
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

Leukemic transformation of anaplastic large-cell lymphoma.

2011-10 | Journal article
DOI: 10.1182/blood-2010-11-318048
PMID: 22073414
Contributors: Vawda A; Davis J; Vercauteren S
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

Copy number alterations at polymorphic loci may be acquired somatically in patients with myelodysplastic syndromes.

2011-04 | Journal article
DOI: 10.1016/j.leukres.2010.08.003
PMID: 20801506
Contributors: Starczynowski DT; Vercauteren S; Sung S; Brooks-Wilson A; Lam WL; Karsan A
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

Array comparative genomic hybridization of peripheral blood granulocytes of patients with myelodysplastic syndrome detects karyotypic abnormalities.

2010-07 | Journal article
DOI: 10.1309/ajcph27zizejlorf
PMID: 20551276
Contributors: Vercauteren SM; Sung S; Starczynowski DT; Lam WL; Bruyere H; Horsman DE; Tsang P; Leitch H; Karsan A
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

Reduction in multi-lineage and erythroid progenitors distinguishes myelodysplastic syndromes from non-malignant cytopenias.

2009-12 | Journal article
DOI: 10.1016/j.leukres.2009.03.019
PMID: 19414193
Contributors: Vercauteren SM; Bashashati A; Wu D; Brinkman RR; Eaves C; Eaves A; Karsan A
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival.

2008-10 | Journal article
DOI: 10.1182/blood-2007-11-122028
PMID: 18663149
Contributors: Starczynowski DT; Vercauteren S; Telenius A; Sung S; Tohyama K; Brooks-Wilson A; Spinelli JJ; Eaves CJ; Eaves AC; Horsman DE et al.
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

Improved survival in HIV-associated diffuse large B-cell lymphoma with the addition of rituximab to chemotherapy in patients receiving highly active antiretroviral therapy.

2007 | Journal article
DOI: 10.1310/hct0803-132
PMID: 17621460
Contributors: Ezzat H; Filipenko D; Vickars L; Galbraith P; Li C; Murphy K; Montaner JS; Harris M; Hogg RS; Vercauteren S et al.
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

Primitive AML progenitors from most CD34(+) patients lack CD33 expression but progenitors from many CD34(-) AML patients express CD33.

2007 | Journal article
DOI: 10.1080/14653240601164042
PMID: 17453971
Contributors: Vercauteren S; Zapf R; Sutherland H
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

Constitutively active Notch4 promotes early human hematopoietic progenitor cell maintenance while inhibiting differentiation and causes lymphoid abnormalities in vivo.

2004-10 | Journal article
DOI: 10.1182/blood-2004-01-0204
PMID: 15231576
Contributors: Vercauteren SM; Sutherland HJ
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

Telomerase is limiting the growth of acute myeloid leukemia cells.

2003-12 | Journal article
DOI: 10.1038/sj.leu.2403177
PMID: 14562114
Contributors: Röth A; Vercauteren S; Sutherland HJ; Lansdorp PM
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

CD133 (AC133) expression on AML cells and progenitors.

2001 | Journal article
DOI: 10.1080/146532401317248054
PMID: 11953029
Contributors: Vercauteren SM; Sutherland HJ
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

Detection and clinical significance of human acute myeloid leukaemia progenitors capable of long-term proliferation in vitro.

2001-08 | Journal article
DOI: 10.1046/j.1365-2141.2001.02927.x
PMID: 11529847
Contributors: Sutherland H; Blair A; Vercauteren S; Zapf R
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central

Human B7-1 is more efficient than B7-2 in providing co-stimulation for alloantigen-specific T cells.

1996-09 | Journal article
DOI: 10.1002/eji.1830260946
PMID: 8814278
Contributors: van Dijk AM; Otten HG; Vercauteren SM; Kessler FL; de Boer M; Verdonck LF; de Gast GC
Source: Self-asserted source
Suzanne Vercauteren via Europe PubMed Central
How many people are using ORCID?